0420B |
Betahydroxybutyric Acid, Blood |
0420FL |
Betahydroxybutyric Acid, Fluid |
0512B |
Barbiturates Screen, Blood |
0512SP |
Barbiturates Screen, Serum/Plasma |
0512U |
Barbiturates Screen, Urine |
0642SP |
Betahydroxybutyric Acid, Serum/Plasma |
0642U |
Betahydroxybutyric Acid, Urine |
0645FL |
Bicarbonate, Fluid |
0645U |
Bicarbonate, Urine |
0719B |
Bromazolam, Blood |
0719SP |
Bromazolam, Serum/Plasma |
0719U |
Bromazolam (Qualitative), Urine |
0771B |
Brorphine, Blood |
0771SP |
Brorphine, Serum/Plasma |
0771U |
Brorphine, Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
4127ME |
Buprenorphine and Metabolite - Total (Qualitative), Meconium |
6921H |
Barbiturates Screen, Hair |
8620B |
Barbiturates Panel, Blood |
8620FL |
Barbiturates Panel, Fluid |
8620ME |
Barbiturates Panel (Qualitative), Meconium |
8620SP |
Barbiturates Panel, Serum/Plasma |
8620TI |
Barbiturates Panel, Tissue |
8620U |
Barbiturates Panel, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |